Daewon Pharm (003220) — Cash Flow Reinvestment Rate
Daewon Pharm (003220) has a Cash Flow Reinvestment Rate of 0.52x as of December 2025, reinvesting ₩15.94 Billion (capex ₩13.07 Billion plus investments ₩2.87 Billion) from operating cash flow of ₩30.61 Billion. Check 003220 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Daewon Pharm Cash Flow Reinvestment Rate (2011–2025)
Historical reinvestment intensity for Daewon Pharm across 15 annual periods. Explore 003220 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Daewon Pharm (2011–2025)
Year-by-year capital reinvestment analysis for Daewon Pharm. For live market cap and broader valuation context, see 003220 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.14x | ₩48.21 Billion | ₩42.31 Billion | ₩42.13 Billion | ▼ -48.1% |
| 2024 | 2.20x | ₩65.99 Billion | ₩30.04 Billion | ₩53.58 Billion | ▲ +27.9% |
| 2023 | 1.72x | ₩88.88 Billion | ₩51.73 Billion | ₩20.61 Billion | ▲ +39.5% |
| 2022 | 1.23x | ₩41.05 Billion | ₩33.33 Billion | ₩13.37 Billion | ▲ +35.6% |
| 2021 | 0.91x | ₩20.36 Billion | ₩22.41 Billion | ₩4.10 Billion | ▲ +99.2% |
| 2020 | 0.46x | ₩11.38 Billion | ₩24.95 Billion | ₩11.35 Billion | ▼ -68.8% |
| 2019 | 1.46x | ₩45.24 Billion | ₩30.97 Billion | ₩33.03 Billion | ▲ +39.8% |
| 2018 | 1.04x | ₩41.81 Billion | ₩40.03 Billion | ₩40.82 Billion | ▼ -72.8% |
| 2017 | 3.84x | ₩16.39 Billion | ₩4.27 Billion | ₩14.71 Billion | ▲ +96.1% |
| 2016 | 1.96x | ₩40.74 Billion | ₩20.79 Billion | ₩20.57 Billion | ▲ +142.1% |
| 2015 | 0.81x | ₩20.89 Billion | ₩25.82 Billion | ₩19.80 Billion | ▼ -21.5% |
| 2014 | 1.03x | ₩17.98 Billion | ₩17.45 Billion | ₩15.84 Billion | ▼ -24.7% |
| 2013 | 1.37x | ₩16.85 Billion | ₩12.32 Billion | ₩9.85 Billion | ▲ +472.4% |
| 2012 | 0.24x | ₩3.30 Billion | ₩13.83 Billion | ₩3.30 Billion | ▼ -58.0% |
| 2011 | 0.57x | ₩10.19 Billion | ₩17.93 Billion | ₩10.19 Billion | — |